This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Nipah Virus Fusion Protein Site IV Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for nipah virus fusion protein site IV. It is affinity purified by protein A. It can be applied to IP of nipah virus fusion protein site IV.
Specifications
Target Information
The nipah virus fusion protein F2, part of the paramyxovirus family, contains a series of cleavage sites that are crucial for its activation. Among these, site IV is a critical juncture for the F2 protein's maturation, although the exact role and mechanism of site IV in the Nipah virus are not extensively detailed in the literature. Generally, for paramyxoviruses, cleavage at specific sites within the F2 protein is essential for its transition from a pre-fusion to a post-fusion state, which is necessary for the fusion of the viral envelope with the host cell membrane. Site IV, if present and functionally analogous to other paramyxoviruses, could be a point of regulation or a checkpoint in the F2 protein's lifecycle. Targeting this site could potentially interfere with the protein's ability to undergo the necessary conformational changes for fusion, thereby inhibiting the virus's entry into host cells.
Shipping and Storage
This product is shipped at ambient temperature. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Aguilar, Hector C., et al. "A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F)." Journal of Biological Chemistry 284.3 (2009): 1628-1635.